MoneyWorks4Me

Nectar Lifesciences - Quaterly Results

14 Aug 2025 Evaluate
The sales is pegged at Rs. 2806.71 millions for the June 2025 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 3593.00 millions during the year-ago period.The Net Loss for the quarter ended June 2025 is Rs. -632.32 millions as compared to Net Profit of Rs. 29.69 millions of corresponding quarter ended June 2024Operating profit Margin for the quarter ended June 2025 slipped to -615.45% as compared to 403.54% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 2806.71 3593.00 -21.88 2806.71 3593.00 -21.88 16730.75 16856.32 -0.74
Other Income 3.50 5.51 -36.48 3.50 5.51 -36.48 18.91 130.30 -85.49
PBIDT -615.45 403.54 -252.51 -615.45 403.54 -252.51 -245.67 1661.35 -114.79
Interest 186.95 199.77 -6.42 186.95 199.77 -6.42 745.78 871.42 -14.42
PBDT -802.40 203.77 -493.78 -802.40 203.77 -493.78 -991.45 789.93 -225.51
Depreciation 165.16 154.60 6.83 165.16 154.60 6.83 623.89 607.18 2.75
PBT -967.56 49.17 -2067.79 -967.56 49.17 -2067.79 -1615.34 182.75 -983.91
TAX -335.24 19.48 -1820.94 -335.24 19.48 -1820.94 -478.53 132.74 -460.50
Deferred Tax -335.24 19.48 -1820.94 -335.24 19.48 -1820.94 -478.53 132.74 -460.50
PAT -632.32 29.69 -2229.74 -632.32 29.69 -2229.74 -1136.81 50.01 -2373.17
Equity 224.26 224.26 0.00 224.26 224.26 0.00 224.26 224.26 0.00
PBIDTM(%) -18.09 9.65 -287.34 -21.93 11.23 -295.24 -1.29 8.62 -114.91
Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..